Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BE vs GSK✓SelectedUSD · GSKBE vs GSK performance historyLatest closeAs of-15.30%11/20
Stock and ETF performance explorer

BE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.5%
GSK return
+6.1%
Excess return
+46.3%
Maximum drawdown
-58.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-15.3%-0.1%-15.2%-15.4%
7D-25.8%-5.3%-20.5%-29.0%
30D-40.3%-3.7%-36.6%-41.6%
3M-29.7%-7.3%-22.4%-32.4%
6M-49.6%-4.2%-45.3%-49.7%
YTD+63.9%+0.9%+63.0%+84.4%
1Y+52.5%+7.3%+45.2%+71.5%
All+52.5%+6.1%+46.3%+71.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling